Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Is a randomized, double-blind, placebo-controlled trial to determine the behavior of
hyperglycemia and postprandial lipemia after a standard mixed meal load in patients with
carbohydrate intolerance treated with acarbose.
Phase:
Phase 4
Details
Lead Sponsor:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran